These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 32763293)

  • 1. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
    El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
    Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of the long non-coding RNA FAM83H-AS1 in gastric cancer and its clinical significance.
    Da J; Liu P; Wang R; Bu L
    Pathol Res Pract; 2019 Oct; 215(10):152616. PubMed ID: 31493939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating long non-coding RNA AFAP1-AS1 is a potential diagnostic biomarker for non-small cell lung cancer.
    Li W; Li N; Kang X; Shi K
    Clin Chim Acta; 2017 Dec; 475():152-156. PubMed ID: 29080690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
    Gong YB; Zou YF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of lncRNA
    Yang F; Lv SX; Lv L; Liu YH; Dong SY; Yao ZH; Dai XX; Zhang XH; Wang OC
    Onco Targets Ther; 2016; 9():7039-7045. PubMed ID: 27895496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA FAM83H-AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer.
    El-Ashmawy NE; Al-Ashmawy GM; Hamouda SM
    Cell Biochem Funct; 2021 Apr; 39(3):350-356. PubMed ID: 33159470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein.
    Dou Q; Xu Y; Zhu Y; Hu Y; Yan Y; Yan H
    Eur J Pharmacol; 2019 Jun; 852():134-141. PubMed ID: 30831080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J; Hu D; Yang Y; Geng J
    Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA FAM83H-AS1 acts as a potential oncogenic driver in human ovarian cancer.
    Yuan X; Huang Y; Guo M; Hu X; Li P
    J Ovarian Res; 2021 Jan; 14(1):6. PubMed ID: 33413565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer.
    Zhang J; Feng S; Su W; Bai S; Xiao L; Wang L; Thomas DG; Lin J; Reddy RM; Carrott PW; Lynch WR; Chang AC; Beer DG; Guo YM; Chen G
    Sci Rep; 2017 Feb; 7():42819. PubMed ID: 28198463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA FAM83H-AS1 promotes oesophageal squamous cell carcinoma progression via miR-10a-5p/Girdin axis.
    Feng B; Wang G; Liang X; Wu Z; Wang X; Dong Z; Guo Y; Shen S; Liang J; Guo W
    J Cell Mol Med; 2020 Aug; 24(16):8962-8976. PubMed ID: 32583631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
    Cao W; Peng T; Zhou Y
    J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
    Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
    Front Genet; 2022; 13():760514. PubMed ID: 35273635
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
    Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.
    Liu W; Li Y; Zhang Y; Shen X; Su Z; Chen L; Cai W; Wang F; Ju S
    Pathol Res Pract; 2020 Jan; 216(1):152757. PubMed ID: 31785996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormally expressed long noncoding RNA B3GALT5-AS1 may serve as a biomarker for the diagnostic and prognostic of gastric cancer.
    Feng W; Zong W; Li Y; Shen X; Cui X; Ju S
    J Cell Biochem; 2020 Jan; 121(1):557-565. PubMed ID: 31338903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma.
    Gong W; Tian M; Qiu H; Yang Z
    Cancer Biomark; 2017 Dec; 20(4):417-424. PubMed ID: 28946548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAM83H-AS1 is upregulated and predicts poor prognosis in colon cancer.
    Yang L; Cui J; Wang Y; Tan J
    Biomed Pharmacother; 2019 Oct; 118():109342. PubMed ID: 31545230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.